Interest in is back, according to interviews with 10 scientists and company executives. (Reuters)
Personalized using natalizumab (Tysabri) trough levels appeared feasible in relapsing-remitting multiple sclerosis in the first phase of the NEXT-MS trial. (Journal of Neurology, Neurosurgery, and Psychiatry)
Ubrogepant (Ubrelvy) halted migraine attacks better than placebo in a phase III trial. (The Lancet)
Neurologists offered suggestions to and improve care. (JAMA Neurology)
A higher glycemic index and glycemic load diet were linked with progression. (Annals of Neurology)
Food insecurity was linked with a , lower memory scores, and faster memory decline. (JAMA Network Open)
The rare APOE-R136S (Christchurch) variant APOE4-driven Alzheimer's pathologies in mouse and human neuron models. (Nature Neuroscience)
Intestinal inflammation was associated with age and in a cohort study. (Scientific Reports)
Sex differences in were linked with Alzheimer's disease. (Alzheimer's & Dementia)
Nanoplastics influenced Parkinson's disease-associated in mice. (Science Advances)
A brain-penetrant USP30 inhibitor in a Parkinson's disease mouse model. (Nature Communications)
The New York Times offered a close look at the lives of with autopsy evidence of chronic traumatic encephalopathy (CTE).